These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
941 related articles for article (PubMed ID: 18093111)
1. The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease. Lee JH; Jung JY; Bang D J Eur Acad Dermatol Venereol; 2008 May; 22(5):590-5. PubMed ID: 18093111 [TBL] [Abstract][Full Text] [Related]
2. Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis. Arabaci T; Kara C; Ciçek Y J Periodontal Res; 2009 Dec; 44(6):718-25. PubMed ID: 19076988 [TBL] [Abstract][Full Text] [Related]
3. The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration. Nolan A; Baillie C; Badminton J; Rudralingham M; Seymour RA J Oral Pathol Med; 2006 Sep; 35(8):461-5. PubMed ID: 16918596 [TBL] [Abstract][Full Text] [Related]
4. Systematic review: the efficacy of topical hyaluronic acid on oral ulcers. Casale M; Moffa A; Vella P; Rinaldi V; Lopez MA; Grimaldi V; Salvinelli F J Biol Regul Homeost Agents; 2017 Dec; 31(4 Suppl 2):63-69. PubMed ID: 29202564 [TBL] [Abstract][Full Text] [Related]
5. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease. Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940 [TBL] [Abstract][Full Text] [Related]
6. The assessment of oral health-related quality of life by factor analysis in patients with Behcet's disease and recurrent aphthous stomatitis. Mumcu G; Hayran O; Ozalp DO; Inanc N; Yavuz S; Ergun T; Direskeneli H J Oral Pathol Med; 2007 Mar; 36(3):147-52. PubMed ID: 17305636 [TBL] [Abstract][Full Text] [Related]
7. A composite index for determining the impact of oral ulcer activity in Behcet's disease and recurrent aphthous stomatitis. Mumcu G; Sur H; Inanc N; Karacayli U; Cimilli H; Sisman N; Ergun T; Direskeneli H J Oral Pathol Med; 2009 Nov; 38(10):785-91. PubMed ID: 19614861 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the clinical features of recurrent aphthous stomatitis and Behçet's disease. Oh SH; Han EC; Lee JH; Bang D Clin Exp Dermatol; 2009 Aug; 34(6):e208-12. PubMed ID: 19549229 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study. Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631 [TBL] [Abstract][Full Text] [Related]
10. Conjunctival ulcers in Behçet's disease. Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237 [TBL] [Abstract][Full Text] [Related]
12. The efficacy of the bioadhesive patches containing licorice extract in the management of recurrent aphthous stomatitis. Moghadamnia AA; Motallebnejad M; Khanian M Phytother Res; 2009 Feb; 23(2):246-50. PubMed ID: 18853400 [TBL] [Abstract][Full Text] [Related]
13. Low-dose natural human interferon-alpha lozenges in the treatment of Behçet's syndrome. Kiliç H; Zeytin HE; Korkmaz C; Mat C; Gül A; Coşan F; Dinç A; Simşek I; Süt N; Yazici H Rheumatology (Oxford); 2009 Nov; 48(11):1388-91. PubMed ID: 19717547 [TBL] [Abstract][Full Text] [Related]
14. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations. Sun A; Wang JT; Chia JS; Chiang CP J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742 [TBL] [Abstract][Full Text] [Related]
15. [Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases]. Fontes V; Machet L; Huttenberger B; Lorette G; Vaillant L Ann Dermatol Venereol; 2002 Dec; 129(12):1365-9. PubMed ID: 12536172 [TBL] [Abstract][Full Text] [Related]
16. Transient benefits for topical hyaluronic acid in recurrent aphthous ulceration. Porter S Evid Based Dent; 2007; 8(2):52. PubMed ID: 17589493 [TBL] [Abstract][Full Text] [Related]
17. Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study. Nanke Y; Kamatani N; Okamoto T; Ogiuchi H; Kotake S Drugs R D; 2008; 9(6):455-9. PubMed ID: 18989994 [TBL] [Abstract][Full Text] [Related]
18. Lactic acid 5 percent mouthwash is an effective mode of therapy in treatment of recurrent aphthous ulcerations. Sharquie KE; Al-Tammimy SM; Al-Mashhadani S; Hayani RK; Al-Nuaimy AA Dermatol Online J; 2006 Dec; 12(7):2. PubMed ID: 17459288 [TBL] [Abstract][Full Text] [Related]
19. Oral health is impaired in Behçet's disease and is associated with disease severity. Mumcu G; Ergun T; Inanc N; Fresko I; Atalay T; Hayran O; Direskeneli H Rheumatology (Oxford); 2004 Aug; 43(8):1028-33. PubMed ID: 15161982 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]